PARS - Predicting Amyloid Beta Positivity in Cognitively Normal Individuals.

When to use?

When physicians want to make a decision regarding obtaining amyloid PET imaging from patients.

LIMITATIONS

Only for Cognitively Unimpaired individuals.

Interpretation

Higher risk score indicate higher probability of amyloid positivity. Decision on proceeding with confirmatory testing should be based on physicians clinical impression of patient and availability of resources.

Evidence

This app is developed based on results of studies by our research team at NEURODICTION on A4 dataset. The manuscript is currently under review. Please contact us if you have questions or need a copy of the results.

DISCLAIMER & TERMS OF USE

Note. This app does not record any information entered by users.

These Tools are intended for information purposes only. All our contents must be re-checked based on your own knowledge, and SHOULD NOT BE USED FOR INDIVIDUAL PATIENT CARE, NOR SHOULD THEY SUBSTITUTE FOR CLINICAL JUDGMENT.

See our full disclaimer.

Migraine1-OTC2: HTML Embed